Quarter Financials

Madrigal Pharmaceuticals, Inc. (MDGL)

$236.54

-11.99 (-4.82%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Net Income -99-86-78-88-83-72-58-65
Dividend Paid --------
Retained Earnings -1,224-1,125-1,040-963-877-796-725-667

PPE Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Capital Expenditure -0-0-0-0-0-0-0-0
Net PPE 21112212

Intangible and Goodwill Schedule

Year 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
New Purchases -55-38-79-14-13-199-92-69
Intangible and Goodwill --------